Neuroinflammation has been implicated in the pathogenesis of several neurologic and psychiatric disorders. Microglia are key drivers of neuroinflammation and, in response to different inflammatory stimuli, overexpress a proinflammatory signature of genes. Among these,
Ch25h
is a gene overexpressed in brain tissue from Alzheimer’s disease as well as various mouse models of neuroinflammation.
Ch25h
encodes cholesterol 25-hydroxylase, an enzyme upregulated in activated microglia under conditions of neuroinflammation, that hydroxylates cholesterol to form 25-hydroxycholesterol (25HC). 25HC can be further metabolized to 7α,25-dihydroxycholesterol, which is a potent chemoattractant of leukocytes. We have previously shown that 25HC increases the production and secretion of the proinflammatory cytokine, IL-1β, by primary mouse microglia treated with lipopolysaccharide (LPS). In the present study, wildtype (
WT
) and
Ch25h
-knockout (
KO
) mice were peripherally administered LPS to induce an inflammatory state in the brain. In LPS-treated
WT
mice,
Ch25h
expression and 25HC levels increased in the brain relative to vehicle-treated
WT
mice. Among LPS-treated
WT
mice, females produced significantly higher levels of 25HC and showed transcriptomic changes reflecting higher levels of cytokine production and leukocyte migration than
WT
male mice. However, females were similar to males among LPS-treated
KO
mice.
Ch25h
-deficiency coincided with decreased microglial activation in response to systemic LPS. Proinflammatory cytokine production and intra-parenchymal infiltration of leukocytes were significantly lower in
KO
compared to
WT
mice. Amounts of IL-1β and IL-6 in the brain strongly correlated with 25HC levels. Our results suggest a proinflammatory role for 25HC in the brain following peripheral administration of LPS.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12974-024-03233-1.